Skip to main content

Table 1 Patient and tumor characteristics by self-identified race

From: Insulin resistance contributes to racial disparities in breast cancer prognosis in US women

 

Total

White

Black

p value

N(%)

515 (100%)

428 (83%)

87 (17%)

 

Age, mean (SD)

58.3 (12.4)

58.3 (12.3)

58.1 (13.2)

0.9

Metabolic characteristics

 BMI, mean (kg/m2)

27.1 (6.4)

26.3 (5.9)

31.2 (6.8)

< .0001

 Obese (BMI ≥ 30 kg/m2)

120 (24%)

79 (19%)

41 (47%)

< .0001

 Abdominal obesity (WC > 88 cm)

332 (72%)

250 (67%)

82 (96%)

< .0001

 Metabolic syndrome

120 (23%)

85 (20%)

35 (40%)

< .0001

Comorbidities

 Charlson Comorbidity Index (≥ 1)

284 (55%)

225 (53%)

59 (68%)

0.01

Tumor characteristics

 Tumor size, cm

1.5 (1.2)

1.5 (1.2)

1.7 (1.2)

0.2

 Stage

   

0.05

  I

327 (64%)

281 (66%)

46 (53%)

 

  II

169 (33%)

133 (31%)

36 (41%)

 

  III

19 (4%)

14 (3%)

5 (6%)

 

 Insulin resistant (HOMA-IR >  2.8)

57 (11%)

42 (10%)

15 (17%)

0.04

 NPI > 4.4

87 (17%)

63 (15%)

24 (28%)

0.004

 iNPI >5.4

17 (3%)

9 (2%)

8 (9%)

0.001

Tumor hormone receptor status

 Estrogen receptor positive

433 (88%)

371 (91%)

62 (77%)

0.0003

 Progesterone receptor positive

405 (83%)

346 (85%)

59 (73%)

0.01

 Her2 positive

31 (6%)

25 (6%)

6 (8%)

0.65

 Triple negative

38 (8%)

28 (6%)

13 (16%)

0.01

Screening behavior

 Mammogram ≥ 2 years before diagnosis

108 (22%)

91 (22%)

17 (20%)

0.6

Lifestyle factors

 Smoking: never smoker

265 (54%)

211 (52%)

54 (64%)

0.04

 Alcohol: > 2 drinks/week

122 (25%)

118 (29%)

4 (5%)

< .0001

 Diet: very good/excellent diet

264 (54%)

239 (59%)

25 (30%)

< .0001

 Physical activity: sedentary

236 (49%)

184 (47%)

52 (60%)

0.02

Socioeconomic factors

 Education: < college education

85 (18%)

54 (14%)

31 (38%)

< .0001

 Income: < $75,000/year

70 (40%)

43 (31%)

27 (75%)

< .0001

 Insurance: commercial insurance

436 (89%)

364 (90%)

72 (84%)

0.1